Home › Gastrointestinal Stromal Tumors › Arizona
Gastrointestinal Stromal Tumors clinical trials in Arizona
5 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in Arizona.
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07218926A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
- GSK Investigational Site, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07585266DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- Mayo Clinic Cancer Center, Phoenix
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06655246A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
- HonorHealth, Scottsdate
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06630234From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.